tbuckley/cabot-search huggingface dataset:
P2.01-121 Genomic Profiling of Pulmonary Lymphoepithelioma-Like Carcinoma
Authors: C. Zhou, Z. Xie, Y. Qin, X. Xie, X. Lin, J. Zhang, M. Ouyang, B. Li, J. Liu, S. Mai, L. Zhang
Journal: Journal of Thoracic Oncology (2018)
MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB
Authors: K. Arbour, R. Shen, A. Plodkowski, H. Rizvi, A. Ni, N. Long, D. Halpenny, F. Sanchez-Vega, C. Rudin, G. Riely, M. Hellmann
Journal: Journal of Thoracic Oncology (2018)
Prospective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial
Authors: X. García Albéniz, V. Alonso, P. Escudero, M. Méndez, J. Gallego Plazas, J.R. Rodriguez, A. Salud Salvia, J. Fernández-Plana, H. Manzano Alemany, M. Zanui, E. Falcó, J. Feliu Batlle, M. Gil-Raga, C. Fernández-Martos, U. Bohn Sarmiento, M.C. Alonso López, V. Calderero Aragón, F. Rojo, M. Cuatrecasas, J. Maurel
Journal: Annals of Oncology (2018)
MA20.01 Lung Cancer Screenee Selection by USPSTF versus PLCOm2012 Criteria – Preliminary ILST Findings
Authors: M. Tammemägi, R. Myers, M. Ruparel, N. Taghizadeh, S. Atkar-Khattra, J. Dickson, S. Quaife, A. Bhowmik, P. Burrowes, P. Maceachern, E. Bedard, J. Yee, J. Mayo, J. Liu, K. Fong, A. Tremblay, S. Janes, S. Lam
Journal: Journal of Thoracic Oncology (2018)
P3.01-25 Feasibility of Moderate Hypofractionated Thoracic Irradiation for Non-Small Cell Lung Cancer Patients with Very Limited Lung Function
Authors: F. Manapov, O. Roengvoraphoj, J. Taugner, M. Dantes, L. Käsmann, C. Wijaya, N. Schmidt-Hegemann, C. Belka, C. Eze
Journal: Journal of Thoracic Oncology (2018)
P1.15-04 Practice Patterns Regarding Multidisciplinary Cancer Management for NSCLC and implemetantion: Results of National Survey in México
Authors: S. Campos-Gomez, K.A. Campos-Gomez, O. Macedo-Pérez, J.J. Valdéz Andrade, O. Arrieta
Journal: Journal of Thoracic Oncology (2018)
Abstract 11886: The Impact of Poor Understanding of Heart Failure and Its Symptoms on Self-care
Authors: Kyoung Suk Lee, Debra K Moser, Kathleen Dracup
Journal: Circulation (2016)

Introduction: A comprehensive understanding of heart failure (HF) and its symptoms is one of the goals of patient education. Patients cannot be expected to adequately perform self-care and respond to symptoms appropriately with incomplete understanding of HF and its symptoms. Purpose: To examine whether levels of understanding of HF and its symptoms predicts self-care in HF patients who had a recent hospitalization for HF symptoms. Methods: Patients with HF (N=577, mean 66 years, 41% female, 35% NYHA III/IV) completed the 9-item European HF Self-care Behavior scale to assess self-care. The HF Knowledge Questionnaire was used to assess knowledge of HF and its symptoms. Three groups were formed by their different levels of understanding of HF and its symptoms: poor, moderate, and complete. Linear regression was used to determine whether levels of understanding of HF and its symptoms predicted self-care after controlling for age, gender, education, marital status, comorbidity, NYHA functional class, and depressive symptoms. Results: Of 577 patients, 16% and 32% of the patients had poor and moderate understanding of HF and its symptoms, respectively. Levels of understanding of HF and its symptoms independently predicted self-care. Compared with patients with complete understanding, those with poor and moderate understanding were more likely to inadequately perform self-care (standardized β=0.24 and 95% CI 3.39-6.48; standardized β=0.12 95% CI 0.53-2.93, respectively). Conclusions: A large minority of patients with HF had poor or moderate understanding of HF and its symptoms. Levels of understanding of HF and its symptoms predicted poor self-care behaviors in these patients. Thus, patient education must be designed to help patients achieve a thorough understanding of the disease and its symptoms to ensure successful self-care among HF patients.
P3.01-95 EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
Authors: K. Syrigos, S. Tsagouli, I. Gkiozos, M. Paraskeva, I. Kotteas, S. Tsimpoukis, M. Zontanos, D. Grapsa
Journal: Journal of Thoracic Oncology (2018)
Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Authors: S. Popat, H.R. Kim, M.-J. Ahn, J.C.-H. Yang, J.-Y. Han, M.J. Hochmair, K.H. Lee, A. Delmonte, M.R. Garcia Campelo, D.-W. Kim, F. Griesinger, E. Felip, R. Califano, A.I. Spira, S. Gettinger, M. Tiseo, J. Haney, D. Kerstein, D.R. Camidge
Journal: Annals of Oncology (2018)
MA10.01 Antibiotic Use and PD-1 Inhibitors: Shorter Survival in Lung Cancer, Especially When Given Intravenously. Type of Infection Also Matters
Authors: X. Mielgo-Rubio, L. Chara, M. Sotelo-Lezama, R. Lopez Castro, J. Rubio-Martínez, A. Velastegui, C. Olier-Garate, S. Falagan, I. Gómez-Barreda, P. Bautista-Sanz, J. Silva-Ruiz, J. Moreno Rubio, C. López, A. Cardeña-Gutiérrez, E. Pérez-Fernández, M. Sereno Moyano
Journal: Journal of Thoracic Oncology (2018)
68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung Carcinoid
Authors: Lucia Leccisotti, Margherita Lorusso, Elisa Giannetta, Andrea M. Isidori, Vittoria Rufini
Journal: Clinical Nuclear Medicine (2018)

We report the case of a 43-year-old man with a history of lung carcinoid and a recent detection of thyroid nodules by ultrasound. The cytological analysis raised the suspicion of medullary thyroid carcinoma; however, calcitonin and carcinoembryonic antigen levels were in reference range. Considering the previous diagnosis of lung carcinoid, the patient underwent whole-body Ga-DOTATOC PET/CT. The images showed focal radiopharmaceutical uptake in both thyroid lobes. After thyroidectomy, the histology and immunohistochemistry (negative for calcitonin and positive for chromogranin A) confirmed the neuroendocrine origin of the thyroid nodules, possibly referable to previous lung carcinoid.
P1.05-03 Significance of Lymph Node SUVmax In Predicting Nodal Metastasis By EBUS in Lung Cancer Patients
Authors: M. Gulak, C. Anstee, S. Gilbert, A. Seely, F. Shamji, S. Sundaresan, P. Villeneuve, D. Maziak
Journal: Journal of Thoracic Oncology (2018)
nab-paclitaxel + carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND.sqm study
Authors: D.R. Spigel, R.M. Jotte, S. Ponce Aix, L. Gressot, D. Morgensztern, M. McCleod, M.A. Socinski, D. Daniel, O. Juan-Vidal, E.S. Kim, H.J. West, T. Chen, R. Bhore, T.J. Ong, C. Gridelli, M. Thomas
Journal: Annals of Oncology (2018)
P1.05-05 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Suspected Malignancy; Current Status and Issues
Authors: H. Kayawake, T. Chen-Yoshikawa, Y. Yutaka, D. Nakajima, M. Hamaji, T. Menju, A. Ohsumi, T. Sato, M. Sonobe, H. Date
Journal: Journal of Thoracic Oncology (2018)
The level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer
Authors: E. Picard, Y. Godet, C. Laheurte, L. Boullerot, E. Lauret Marie Joseph, M. Jacquin, V. Kaulek, G. Eberst, B. Gaugler, P. Jacoulet, M. Gainet-Brun, J. Lahoucarde, H. Almotlak, F. Le Pimpec-Barthes, E. Fabre-Guillevin, C. Borg, V. Westeel, O. Adotevi
Journal: Annals of Oncology (2018)
Long Noncoding RNA lncMUMA Reverses Established Skeletal Muscle Atrophy following Mechanical Unloading
Authors: Zong-Kang Zhang, Jie Li, Daogang Guan, Chao Liang, Zhenjian Zhuo, Jin Liu, Aiping Lu, Ge Zhang, Bao-Ting Zhang
Journal: Molecular Therapy (2018)

Reversing established muscle atrophy following mechanical unloading is of great clinical challenge. Long noncoding RNAs (lncRNAs) have been demonstrated to play important roles in myogenesis. Here we identified a lncRNA (mechanical unloading-induced muscle atrophy-related lncRNA [lncMUMA]) enriched in muscle, which was the most downregulated lncRNA during muscle atrophy development in hindlimb suspension (HLS) mice. The in vitro and in vivo data demonstrated that the decreased expression levels of lncMUMA closely associated with a reduction of myogenesis during mechanical unloading. Mechanistically, lncMUMA promoted myogenic differentiation by functioning as a miR-762 sponge to regulate the core myogenic regulator MyoD in vitro. The enforced expression of lncMUMA relieved the decreases in MyoD protein and muscle mass in miR-762 knockin mice. Therapeutically, the enforced expression of lncMUMA improved the in vitro myogenic differentiation of myoblasts under microgravity simulation, prevented the muscle atrophy development, and reversed the established muscle atrophy in HLS mice. These findings identify lncMUMA as an anabolic regulator to reverse established muscle atrophy following mechanical unloading.
Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
Authors: C.A.T.C. Lunenburg, L.M. Henricks, E. Dreussi, F.P. Peters, M. Fiocco, D. Meulendijks, G. Toffoli, H.-J. Guchelaar, J.J. Swen, E. Cecchin, J.H.M. Schellens, H. Gelderblom
Journal: Annals of Oncology (2018)
KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC)
Authors: J.-P. Machiels, L. Licitra, Y.G. Tao, C.-J. Yen, D. Rischin, J.N. Waldron, B.A. Burtness, V. Gregoire, S.S. Agarwala, J. Yorio, J.-P. Delord, S. Aksoy, S. Ikeda, R.-L. Hong, J.Y. Ge, H. Brown, B. Bidadi, L.L. Siu
Journal: Annals of Oncology (2018)
Gastric GIST Incidentally Detected on 68Ga-PSMA-PET/CT
Authors: Sofia Vaz, Carla Oliveira, Joana C. Castanheira, Ângelo F. Silva, Durval C. Costa
Journal: Clinical Nuclear Medicine (2018)

Prostate-specific membrane antigen (PSMA) is specific for prostate cancer cells; nevertheless when finding uptake in abnormal locations for prostate cancer metastases, it is important to consider other hypothesis, including second cancers. There are several papers about PSMA expression in many different types of cancer, but few reported expression in gastrointestinal stromal tumors (GIST). In this case, we documented the GIST lesion not only by PET/CT but also by gastroscopy and histology. Additionally, PSMA immunochemistry was performed, showing PSMA expression in tumoral GIST cells (not in endothelial cells), evidencing a good correlation between PET/CT image and histology.
Effect of postinjection facial exercise on time of onset of botulinum toxin for glabella and forehead wrinkles: A randomized, controlled, crossover clinical trial
Authors: Murad Alam, Amelia Geisler, Melanie Warycha, Kapila Paghdal, Wanjarus Roongpisuthipong, Daniel I. Schlessinger, Brian R. Chen, Kelly A. Reynolds, Dennis P. West, Emily Poon
Journal: Journal of the American Academy of Dermatology (2018)
Functional Consequences of the Evolution of Matrimony, a Meiosis-Specific Inhibitor of Polo Kinase
Authors: Amanda M Bonner, R Scott Hawley
Journal: Molecular Biology and Evolution (2018)

Meiosis is a defining characteristic of eukaryotes, believed to have evolved only once, over one billion years ago. While the general progression of meiotic events is conserved across multiple diverse organisms, the specific pathways and proteins involved can be highly divergent, even within species from the same genus. Here we investigate the rapid evolution of Matrimony (Mtrm), a female meiosis-specific regulator of Polo kinase (Polo) in Drosophila. Mtrm physically interacts with Polo and is required to restrict the activity of Polo during meiosis. Despite Mtrm's critical role in meiosis, sequence conservation within the genus Drosophila is poor. To explore the functional significance of this rapid divergence, we expressed Mtrm proteins from 12 different Drosophila species in the Drosophila melanogaster female germline. Distantly related Mtrm homologs are able to both physically interact with D. melanogaster Polo and rescue the meiotic defects seen in mtrm mutants. However, these distant homologs are not properly degraded after the completion of meiosis. Rather, they continue to inhibit Polo function in the early embryo, resulting in dominant maternal-effect lethality. We show that the ability of Mtrm to be properly degraded, and thus release Polo, is partially due to residues or motifs found within Mtrm's least-conserved regions. We hypothesize that, while Mtrm regions critical for its meiotic function are under strong purifying selection, changes that occurred in its unconserved regions may have been advantageous, potentially by affecting the timing or duration of meiosis and/or the early embryonic divisions.
Association of Weather With Day-to-Day Incidence of Myocardial Infarction
Authors: Moman A. Mohammad, Sasha Koul, Rebecca Rylance, Ole Fröbert, Joakim Alfredsson, Anders Sahlén, Nils Witt, Tomas Jernberg, James Muller, David Erlinge
Journal: JAMA Cardiology (2018)

<h3>Importance</h3> Whether certain weather conditions modulate the onset of myocardial infarction (MI) is of great interest to clinicians because it could be used to prevent MIs as well as guide allocation of health care resources. <h3>Objective</h3> To determine if weather is associated with day-to-day incidence of MI. <h3>Design, Setting, and Participants</h3> In this prospective, population-based and nationwide setting, daily weather data from the Swedish Meteorological and Hydrological Institute were extracted for all MIs reported to the Swedish nationwide coronary care unit registry, Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART), during 1998 to 2013 and then merged with each MI on date of symptom onset and coronary care unit. All patients admitted to any coronary care unit in Sweden owing to MI were included. A total of 280 873 patients were included, of whom 92 044 were diagnosed as having ST-elevation MI. Weather data were available for 274 029 patients (97.6%), which composed the final study population. Data were analyzed between February 2017 and April 2018. <h3>Exposures</h3> The nationwide daily mean air temperature, minimum air temperature, maximum air temperature, wind velocity, sunshine duration, atmospheric air pressure, air humidity, snow precipitation, rain precipitation, and change in air temperature. <h3>Main Outcomes and Measures</h3> The nationwide daily counts of MI as outcome. <h3>Results</h3> In 274 029 patients, mean (SD) age was 71.7 (12) years. Incidence of MI increased with lower air temperature, lower atmospheric air pressure, higher wind velocity, and shorter sunshine duration. The most pronounced association was observed for air temperature, where a 1-SD increase in air temperature (7.4°C) was associated with a 2.8% reduction in risk of MI (unadjusted incidence ratio, 0.972; 95% CI, 0.967-0.977;<i>P</i>&lt;.001). Results were consistent for non–ST-elevation MI as well as ST-elevation MI and across a large range of subgroups and health care regions. <h3>Conclusions and Relevance</h3> In this large, nationwide study, low air temperature, low atmospheric air pressure, high wind velocity, and shorter sunshine duration were associated with risk of MI with the most evident association observed for air temperature.
P1.01-15 ROS1-Rearranged Non-Small Cell Lung Cancer Is Associated with High Rate of Venous Thromboembolism: Analysis of The METROS Trial
Authors: R. Chiari, B. Ricciuti, L. Landi, A.M. Morelli, A. Delmonte, G. Spitalieri, D. Cortinovis, F. Facchinetti, S. Pilotto, C. Verusio, A. Chella, L. Bonanno, D. Galetta, F. Cappuzzo
Journal: Journal of Thoracic Oncology (2018)
P2.01-112 Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients with Lung Cancer Treated with Nivolumab
Authors: E. Shibata, T. Yokoi, R. Takahashi, K. Mikami, S. Kanemura, Y. Koda, Y. Negi, E. Fujimoto, Y. Akano, A. Tada, T. Minami, K. Kuribayashi, T. Kijima
Journal: Journal of Thoracic Oncology (2018)
P3.04-26 EMPOWER-Lung 4: A Phase 2 Study of Cemiplimab Plus Ipilimumab in the Second-Line Treatment of Advanced NSCLC with PD-L1 &lt;50%
Authors: N. Rizvi, S. Lee, P. Curtis, W. Caldwell, B. Gao, P. Rietschel
Journal: Journal of Thoracic Oncology (2018)
The quality oncology practice initiative program: Experience in Spain
Authors: R. Lopez Lopez, A. Anton Torres, E. Aranda Aguilar, A. Carrato Mena, M. Constenla Figueiras, J.J. Cruz Hernandez, E. Diaz Rubio, M. Feyjoo, J. Garcia Foncillas, P.N. Gascon, V. Guillem Porta, I.S. Lugo Cuan, A. Rogado, C. Camps
Journal: Annals of Oncology (2018)
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial
Authors: Henry D. Mitcheson, Suvajit Samanta, Karen Muldowney, Cathy A. Pinto, Beatriz de A. Rocha, Stuart Green, Nathan Bennett, Paul N. Mudd, Tara L. Frenkl
Journal: European Urology (2018)
MA19.06 Blood Based Biomarkers: RNA, KRAS and PD-L1 Strongly Matching with Tissue and Showing Correlation with Clinical Responses In NSCLC Patient’s
Authors: L. Raez, J. Usher, C. Habaue, K. Danenberg, B. Hunis, Y. Jaimes, S. Rabizadeh, A. Castrellon, P. Danenberg
Journal: Journal of Thoracic Oncology (2018)
P2.09-05 Evaluation of PD-L1-Stained Tumor Cells via the 22C3 and SP-142 Antibodies in Cohort of Patients Treated on KEYNOTE-001
Authors: A. Lisberg, S. Hu-Lieskovan, T. Grogan, J. Carroll, P. Shintaku, M. Han, D. Slamon, S. Dubinett, J. Goldman, D. Elashoff, M. Hellmann, A. Ribas, E. Garon
Journal: Journal of Thoracic Oncology (2018)
OA03.02 Nationwide Comparative Study Of PD-L1 IHC Assays on Lung Cancer: Initial Report Of LC-SCRUM-IBIS Project
Authors: N. Motoi, G. Ishii, Y. Hayashi, K. Tsuta, K. Yoh, S. Matsumoto, K. Goto
Journal: Journal of Thoracic Oncology (2018)
Baseline lymphocyte counts predict distant recurrence in early breast cancer
Authors: G.M. Kim, H.D. Koh, J.H. Kim, B.-W. Park, Y.U. Cho, S.I. Kim, H.S. Park, J.Y. Kim, M.J. Kim, J.H. Jeong, J. Sohn
Journal: Annals of Oncology (2018)
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer
Authors: D. Basile, C. Lisanti, M. Borghi, M. Bartoletti, L. Gerratana, L. Bortot, G. Pelizzari, C. Corvaja, E. Ongaro, S.K. Garattini, V. Fanotto, A. Parnofiello, F. Cortiula, M. Cattaneo, V.J. Andreotti, E. Bertoli, M. Guardascione, G. Miolo, F. Puglisi, A. Buonadonna
Journal: Annals of Oncology (2018)
Clinical outcome with radium-223 (Ra-223) in patients (pts) previously treated with abiraterone (Abi) or enzalutamide (Enza): A retrospective study of real-world (RW) data from pts with metastatic castration-resistant prostate cancer (mCRPC)
Authors: C.S. Higano, B. Tombal, K. Miller, F. Saad, O. Sartor, K. Tangirala, X. Jiao, J. Kalinovsky, C.N. Sternberg
Journal: Annals of Oncology (2018)
Cetuximab in patients with unresectable cutaneous squamous cell carcinoma is safe and effective: A real-life analysis
Authors: F. Peyrade, M. Kogay, J. Viotti, P. Combemale, C. Dutriaux, N. Dupin, C. Robert, L. Mortier, A.-B. Duval-Modeste, S. Dalle, J. De Quatrebarbes, A. Stefan, F. Brunet-Possenti, A. Picard, G. Poissonnet, H. Montaudié
Journal: Annals of Oncology (2018)
P3.04-17 Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada
Authors: U. Ondhia, H. Conter, S. Owen, A. Zhou, J. Nam, S. Singh, A. Abdulla, P. Chu, F. Felizzi, R. Sangha
Journal: Journal of Thoracic Oncology (2018)
Gefitinib with or without pemetrexed in nonsquamous (NS) non-small cell lung cancer (NSCLC) with EGFR mutation (mut): Final overall survival (OS) results from a randomized phase II study
Authors: J.C.-H. Yang, Y. Cheng, H. Murakami, P.-C. Yang, J. He, K. Nakagawa, J.H. Kang, J.-H. Kim, X. Wnag, S. Enatsu, T. Puri, M. Orlando
Journal: Annals of Oncology (2018)
Durable clinical benefit with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line therapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)
Authors: H.-J.J. Lenz, E. Van Cutsem, M.L. Limon, K.Y. Wong, A. Hendlisz, M. Aglietta, P. Garcia-Alfonso, B. Neyns, G. Luppi, D. Cardin, T. Dragovich, U. Shah, A. Atasoy, R. Postema, Z. Boyd, J.-M. Ledeine, M. Overman, S. Lonardi
Journal: Annals of Oncology (2018)
MA11.09 Single-Cell Characterization of the Immunologic Microenvironment in Advanced-Stage, Oncogene-Driven NSCLC
Authors: J. Rotow, C. Mccoach, A. Maynard, D. Naeger, Y. Gesthalter, K.P. Kolli, S. Darmanis, T. Bivona, C. Blakely, J. Weissman
Journal: Journal of Thoracic Oncology (2018)
MA02.11 Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - A Prospective Canadian Study (VALUE)
Authors: D. Ezeife, J. Agulnik, R. Juergens, J. Laskin, S. Laurie, L. Le, D. Hao, G. Bebb, J. Law, S. Skrzypczak, D. Juri, R. Lanman, N. Leighl
Journal: Journal of Thoracic Oncology (2018)
Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)
Authors: T. Cascone, W.N. William, A. Weissferdt, C.H. Leung, L. Federico, C. Haymaker, C. Bernatchez, F.V. Fossella, F.E. Mott, V.A. Papadimitrakopoulou, L. Byers, V.K. Lam, M.C. Godoy, B. Carter, J.J. Lee, A. Vaporciyan, D.L. Gibbons, S.G. Swisher, J.V. Heymach, B. Sepesi
Journal: Annals of Oncology (2018)
Detection of targetable kinase fusions in 7260 patients in an integrated cancer system
Authors: A. Parikh, S.M. Ali, A. Moran, P. Crilley, A.B. Schrock, A. Tan, P. Reddy, V.A. Miller, J.S. Ross, S. Zook, R.H. Alvarez, M. Markman
Journal: Annals of Oncology (2018)
Increase in human West Nile and Usutu virus infections, Austria, 2018
Authors: Stephan W. Aberle, Jolanta Kolodziejek, Christof Jungbauer, Karin Stiasny, Judith H. Aberle, Alexander Zoufaly, Michael Kai Hourfar, Lisa Weidner, Norbert Nowotny
Journal: Eurosurveillance (2018)

Between 28 June and 17 September 2018, 27 cases of human West Nile virus infections were recorded in Austria; four cases of West Nile neuroinvasive disease, 11 cases of West Nile fever, six infections detected by blood donation screening and six imported cases. In addition, 18 cases of human Usutu virus infections (all blood donors) were recorded. This is the highest number of annual infections recorded in Austria since the introduction of both viruses.